HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

D I Marks Selected Research

Primary Myelofibrosis (Myelosclerosis)

11/2010The role of allogeneic SCT in primary myelofibrosis: a British Society for Blood and Marrow Transplantation study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


D I Marks Research Topics

Disease

8Infections
02/2016 - 12/2000
3Leukemia
03/2017 - 10/2004
2Multiple Myeloma
12/2015 - 09/2011
2Residual Neoplasm
03/2014 - 10/2006
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
03/2014 - 04/2008
2Neoplasms (Cancer)
03/2013 - 07/2003
2Human Influenza (Influenza)
01/2012 - 01/2002
1Pneumonia (Pneumonitis)
04/2016
1Mucormycosis
02/2016
1Fusariosis
02/2016
1Hodgkin Disease (Hodgkin's Disease)
11/2015
1Myeloproliferative Disorders (Myeloproliferative Disorder)
08/2015
1Hematologic Neoplasms (Hematological Malignancy)
08/2015
1Philadelphia Chromosome
03/2014
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
02/2014
1Splenomegaly
06/2013
1Second Primary Neoplasms (Neoplasms, Second)
03/2013
1Primary Myelofibrosis (Myelosclerosis)
11/2010
1Multiple Sclerosis
06/2010
1Stenotrophomonas maltophilia bacteremia
06/2010
1T-Cell Lymphoma (Lymphoma, T Cell)
09/2007
1Lymphoma (Lymphomas)
09/2007
1Neutropenia
11/2004
1Pathologic Complete Response
10/2004
1Bronchiolitis Obliterans Syndrome
02/2004
1Fever (Fevers)
02/2004
1Hypotension (Low Blood Pressure)
02/2004
1Graft vs Host Disease (Graft-Versus-Host Disease)
12/2003
1Mycoses (Diseases, Fungus)
04/2001
1Thrombotic Thrombocytopenic Purpura
04/2001
1Disease Progression
12/2000
1Adenoviridae Infections (Adenovirus Infections)
12/2000
1Aspergillosis
05/2000
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2000
1Chromosome Aberrations (Chromosome Abnormalities)
01/2000
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2000

Drug/Important Bio-Agent (IBA)

3Alemtuzumab (Campath)FDA Link
05/2009 - 01/2000
23,4,3',4'-tetrachloroazobenzeneIBA
01/2004 - 07/2003
1Antifungal AgentsIBA
02/2016
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
12/2015
1Prostaglandins FIBA
08/2015
1Imatinib Mesylate (Gleevec)FDA Link
03/2014
1Tyrosine Kinase InhibitorsIBA
03/2014
1Rituximab (Mabthera)FDA Link
02/2014
1Dihydrotachysterol (AT 10)IBA
03/2013
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
11/2004
1C-Reactive ProteinIBA
02/2004
1SteroidsIBA
02/2004
1Zanamivir (Relenza)FDA Link
01/2002
1thiamine triphosphorate (TTP)IBA
04/2001
1Ribavirin (Virazole)FDA LinkGeneric
12/2000
1Antiviral Agents (Antivirals)IBA
12/2000
1Cidofovir (Vistide)FDA Link
12/2000
1antineoplaston A10 (A 10)IBA
12/2000
1AntigensIBA
05/2000
1LatexIBA
05/2000
1Indicators and Reagents (Reagents)IBA
05/2000
1ImmunosorbentsIBA
05/2000
1EnzymesIBA
05/2000

Therapy/Procedure

8Cell Transplantation
04/2016 - 03/2013
5Transplantation
03/2017 - 01/2000
5Therapeutics
09/2011 - 12/2003
5Bone Marrow Transplantation (Transplantation, Bone Marrow)
04/2008 - 01/2000
4Drug Therapy (Chemotherapy)
12/2015 - 10/2006
3Homologous Transplantation
03/2014 - 10/2004
3Stem Cell Transplantation
01/2004 - 04/2001
2Hematopoietic Stem Cell Transplantation
04/2016 - 08/2013
1Autologous Transplantation
11/2015
1Splenectomy
06/2013
1Cell- and Tissue-Based Therapy (Cell Therapy)
06/2010
1Chemoradiotherapy
10/2006
1Immunotherapy
10/2006
1Plasmapheresis
04/2001
1Immunomodulation
12/2000
1Remission Induction
01/2000